サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439688

ラテラルフローリーダー/アッセイ - 世界市場の考察、競合情勢、市場予測（2030年）

Lateral Flow Readers/Assay - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ラテラルフローリーダー/アッセイ - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のラテラルフローリーダー/アッセイの市場規模は、2023年に86億4,000万米ドル、2030年までに121億5,000万米ドルに達し、2024年～2030年の予測期間にCAGRで5.41%の成長が見込まれます。市場は、COVID-19の突然の発生のような感染症の罹患率の増加や、世界の妊娠検査件数の増加により、プラス成長を示しています。さらに、免疫診断製品の分野における急速な技術の進歩、急速な高齢化、迅速診断に関する消費者意識の向上に伴うポイントオブケア検査需要の増加などが、市場成長の主な要因となっており、2024年～2030年の予測期間の世界市場に寄与します。

ラテラルフローリーダー/アッセイの市場力学

ラテラルフローリーダー/アッセイ市場は、さまざまな理由によって製品需要が伸びており、その主な理由の1つは世界中での感染症の増加です。UNAIDSが発表した2022年のデータによると、2020年に世界で約3,770万人がHIVに感染し、新たに約150万人のHIV感染者が報告されました。さらに、HIV感染患者の個別化管理に向けたHIV感染の検出と鑑別への製品承認が、ラテラルフローリーダー/アッセイ市場の成長を後押ししています。

ラテラルフローリーダー/アッセイ市場の成長をもたらすもう1つの要因は、COVID-19パンデミックの発生と、COVID-19の拡大を抑制するための診断検査の差し迫った必要性です。SARS-COV-2ウイルスに関連する高い毒性は世界中でパニック状況を引き起こし、世界中でのさまざまな段階のロックダウンにつながっています。このため、SARS-COV-2ウイルスを検出するための診断法とキットが、感染者と非感染者の双方によりよい医療を提供するために、緊急に必要とされています。

さらに、技術の進歩により、パンデミックによる緊急事態に対応するための信頼性の高い新たな診断キットのニーズに応えるため、数多くの迅速抗原検査が開発され、このことが予測期間（2024年～2030年）のラテラルフローリーダー/アッセイ市場の成長にプラスの影響を与えます。例えば、2022年6月、Novacytは2つのCOVID-19抗原ラテラルフロー検査を発表し、主にポイントオブケアセグメントにおいて、そのCOVID-19製品ポートフォリオを拡大しました。

したがって、さまざまな感染症の診断を促進するために、ラテラルフローリーダー/アッセイは需要の増加を示しており、ラテラルフローリーダー/アッセイ市場全体の成長をもたらしています。

したがって、早期発見は治療にとって不可欠です。適切な検査によって、治療はよりよいものとなります。したがって、感染症の流行は、ラテラルフローリーダー/アッセイに対する需要の増加をもたらし、それによって2024年～2030年の予測期間にラテラルフローリーダー/アッセイ市場の成長に寄与すると見込まれます。

しかし、正確な診断検査や機器の開発における課題や検査結果のばらつきが、ラテラルフローリーダー/アッセイ市場成長の一定の抑制要因となる可能性があります。

ラテラルフローリーダー/アッセイ市場のセグメント分析

ラテラルフローリーダー/アッセイ市場の製品セグメントでは、キット・試薬サブセグメントが予測期間（2024年～2030年）に高いシェアを占める見込みです。これは、これらの製品に関連する特定の機能によるものと考えられます。

このセグメントの優位性は、これらの製品の携帯性によるものです。キット・試薬は信頼性が高く、なじみのある形式であるため、エンドユーザーによる頻繁な大規模検査が可能です。機器を必要としないこれらの製品は、感染者を迅速に特定し、その他の人に疾患を広げないようにすることでリスクを管理する重要なツールです。さらに、いくつかの市場参入企業はキット・試薬の強力なポートフォリオを有しており、現在このセグメントで新製品を発売しています。

当レポートでは、世界のラテラルフローリーダー/アッセイ市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 ラテラルフローリーダー/アッセイ市場レポートのイントロダクション

第2章 ラテラルフローリーダー/アッセイ市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 ラテラルフローリーダー/アッセイ市場の主な要因の分析

  • ラテラルフローリーダー/アッセイ市場の促進要因
    • 感染症の罹患率の増加
    • 妊娠検査件数の増加
    • 免疫診断の製品分野における急速な技術の進歩
  • ラテラルフローリーダー/アッセイ市場の抑制要因と課題
    • 正確な診断検査と機器の開発における課題
    • 検査結果のばらつき
  • ラテラルフローリーダー/アッセイ市場の機会
    • メーカー各社の戦略的事業活動の高まり
    • 新興市場をターゲットにした製品の発売

第5章 ラテラルフローリーダー/アッセイ市場のポーターのファイブフォース分析

第6章 ラテラルフローリーダー/アッセイ市場に対するCOVID-19の影響分析

第7章 ラテラルフローリーダー/アッセイ市場のレイアウト

  • 製品別
    • リーダー
    • キット・試薬
  • 手法別
    • サンドイッチアッセイ
    • 競合アッセイ
    • 多重検出アッセイ
  • 用途別
    • 臨床検査
    • 医薬品開発・品質検査
    • その他
  • エンドユーザー別
    • 病院・診療所
    • 在宅ケア
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 ラテラルフローリーダー/アッセイ市場：世界の企業シェア分析 - 主要3～5社

第9章 ラテラルフローリーダー/アッセイ市場の企業と製品のプロファイル

  • Abbott
  • Quidel Corporation
  • Danaher
  • Siemens Healthineers
  • F. Hoffman-La Roche AG
  • LumiraDx
  • Becton, Dickinson, and Company
  • Eurofins Technologies
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific
  • Hologic, Inc.
  • PerkinElmer Inc.
  • QIAGEN
  • Merck KGaA
  • OPERON
  • Abingdon Health
  • DIALUNOX
  • 3B BlackBio Biotech India Ltd.
  • ADS Biotec Inc. (ADSTEC)

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Lateral Flow Readers/Assay Market in Global (2021-2030)
  • Table 4: Lateral Flow Readers/Assay Market in Global by Product (2021-2030)
  • Table 5: Lateral Flow Readers/Assay Market in Global by Technique (2021-2030)
  • Table 6: Lateral Flow Readers/Assay Market in Global by Application (2021-2030)
  • Table 7: Lateral Flow Readers/Assay Market in Global by End User (2021-2030)
  • Table 8: Lateral Flow Readers/Assay Market in Global by Geography (2021-2030)
  • Table 9: Lateral Flow Readers/Assay Market in North America (2021-2030)
  • Table 10: Lateral Flow Readers/Assay Market in North America by Product (2021-2030)
  • Table 11: Lateral Flow Readers/Assay Market in North America by Technique (2021-2030)
  • Table 12: Lateral Flow Readers/Assay Market in North America by Application (2021-2030)
  • Table 13: Lateral Flow Readers/Assay Market in North America by End User (2021-2030)
  • Table 14: Lateral Flow Readers/Assay Market in North America by Country (2021-2030)
  • Table 15: Lateral Flow Readers/Assay Market in the US (2021-2030)
  • Table 16: Lateral Flow Readers/Assay Market in Canada (2021-2030)
  • Table 17: Lateral Flow Readers/Assay Market in Mexico (2021-2030)
  • Table 18: Lateral Flow Readers/Assay Market in Europe (2021-2030)
  • Table 19: Lateral Flow Readers/Assay Market in Europe by Product (2021-2030)
  • Table 20: Lateral Flow Readers/Assay Market in Europe by Technique (2021-2030)
  • Table 21: Lateral Flow Readers/Assay Market in Europe by Application (2021-2030)
  • Table 22: Lateral Flow Readers/Assay Market in Europe by End User (2021-2030)
  • Table 23: Lateral Flow Readers/Assay Market in Europe by Country (2021-2030)
  • Table 24: Lateral Flow Readers/Assay Market in France (2021-2030)
  • Table 25: Lateral Flow Readers/Assay Market in Germany (2021-2030)
  • Table 26: Lateral Flow Readers/Assay Market in the United Kingdom (2021-2030)
  • Table 27: Lateral Flow Readers/Assay Market in Italy (2021-2030)
  • Table 28: Lateral Flow Readers/Assay Market in Spain (2021-2030)
  • Table 29: Lateral Flow Readers/Assay Market in Russia (2021-2030)
  • Table 30: Lateral Flow Readers/Assay Market in Rest of Europe (2021-2030)
  • Table 31: Lateral Flow Readers/Assay Market in APAC (2021-2030)
  • Table 32: Lateral Flow Readers/Assay Market in APAC by Product (2021-2030)
  • Table 33: Lateral Flow Readers/Assay Market in APAC by Technique (2021-2030)
  • Table 34: Lateral Flow Readers/Assay Market in APAC by Application (2021-2030)
  • Table 35: Lateral Flow Readers/Assay Market in APAC by End User (2021-2030)
  • Table 36: Lateral Flow Readers/Assay Market in APAC by Country (2021-2030)
  • Table 37: Lateral Flow Readers/Assay Market in China (2021-2030)
  • Table 38: Lateral Flow Readers/Assay Market in Japan (2021-2030)
  • Table 39: Lateral Flow Readers/Assay Market in India (2021-2030)
  • Table 40: Lateral Flow Readers/Assay Market in Australia (2021-2030)
  • Table 41: Lateral Flow Readers/Assay Market in South Korea (2021-2030)
  • Table 42: Lateral Flow Readers/Assay Market in Rest of APAC (2021-2030)
  • Table 43: Lateral Flow Readers/Assay Market in Rest of World (2021-2030)
  • Table 44: Lateral Flow Readers/Assay Market in RoW by Product (2021-2030)
  • Table 45: Lateral Flow Readers/Assay Market in RoW by Technique (2021-2030)
  • Table 46: Lateral Flow Readers/Assay Market in RoW by Application (2021-2030)
  • Table 47: Lateral Flow Readers/Assay Market in RoW by End User (2021-2030)
  • Table 48: Lateral Flow Readers/Assay Market in RoW by Region (2021-2030)
  • Table 49: Lateral Flow Readers/Assay Market in Middle East (2021-2030)
  • Table 50: Lateral Flow Readers/Assay Market in Africa (2021-2030)
  • Table 51: Lateral Flow Readers/Assay Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Lateral Flow Readers/Assay Market in Global (2021-2030)
  • Figure 4: Lateral Flow Readers/Assay Market in Global by Product (2021-2030)
  • Figure 5: Lateral Flow Readers/Assay Market in Global by Technique (2021-2030)
  • Figure 6: Lateral Flow Readers/Assay Market in Global by Application (2021-2030)
  • Figure 7: Lateral Flow Readers/Assay Market in Global by End User (2021-2030)
  • Figure 8: Lateral Flow Readers/Assay Market in Global by Geography (2021-2030)
  • Figure 9: Lateral Flow Readers/Assay Market in North America (2021-2030)
  • Figure 10: Lateral Flow Readers/Assay Market in North America by Product (2021-2030)
  • Figure 11: Lateral Flow Readers/Assay Market in North America by Technique (2021-2030)
  • Figure 12: Lateral Flow Readers/Assay Market in North America by Application (2021-2030)
  • Figure 13: Lateral Flow Readers/Assay Market in North America by End User (2021-2030)
  • Figure 14: Lateral Flow Readers/Assay Market in North America by Country (2021-2030)
  • Figure 15: Lateral Flow Readers/Assay Market in the US (2021-2030)
  • Figure 16: Lateral Flow Readers/Assay Market in Canada (2021-2030)
  • Figure 17: Lateral Flow Readers/Assay Market in Mexico (2021-2030)
  • Figure 18: Lateral Flow Readers/Assay Market in Europe (2021-2030)
  • Figure 19: Lateral Flow Readers/Assay Market in Europe by Product (2021-2030)
  • Figure 20: Lateral Flow Readers/Assay Market in Europe by Technique (2021-2030)
  • Figure 21: Lateral Flow Readers/Assay Market in Europe by Application (2021-2030)
  • Figure 22: Lateral Flow Readers/Assay Market in Europe by End User (2021-2030)
  • Figure 23: Lateral Flow Readers/Assay Market in Europe by Country (2021-2030)
  • Figure 24: Lateral Flow Readers/Assay Market in France (2021-2030)
  • Figure 25: Lateral Flow Readers/Assay Market in Germany (2021-2030)
  • Figure 26: Lateral Flow Readers/Assay Market in the United Kingdom (2021-2030)
  • Figure 27: Lateral Flow Readers/Assay Market in Italy (2021-2030)
  • Figure 28: Lateral Flow Readers/Assay Market in Spain (2021-2030)
  • Figure 29: Lateral Flow Readers/Assay Market in Russia (2021-2030)
  • Figure 30: Lateral Flow Readers/Assay Market in Rest of Europe (2021-2030)
  • Figure 31: Lateral Flow Readers/Assay Market in APAC (2021-2030)
  • Figure 32: Lateral Flow Readers/Assay Market in APAC by Product (2021-2030)
  • Figure 33: Lateral Flow Readers/Assay Market in APAC by Technique (2021-2030)
  • Figure 34: Lateral Flow Readers/Assay Market in APAC by Application (2021-2030)
  • Figure 35: Lateral Flow Readers/Assay Market in APAC by End User (2021-2030)
  • Figure 36: Lateral Flow Readers/Assay Market in APAC by Country (2021-2030)
  • Figure 37: Lateral Flow Readers/Assay Market in China (2021-2030)
  • Figure 38: Lateral Flow Readers/Assay Market in Japan (2021-2030)
  • Figure 39: Lateral Flow Readers/Assay Market in India (2021-2030)
  • Figure 40: Lateral Flow Readers/Assay Market in Australia (2021-2030)
  • Figure 41: Lateral Flow Readers/Assay Market in South Korea (2021-2030)
  • Figure 42: Lateral Flow Readers/Assay Market in Rest of APAC (2021-2030)
  • Figure 43: Lateral Flow Readers/Assay Market in Rest of World (2021-2030)
  • Figure 44: Lateral Flow Readers/Assay Market in RoW by Product (2021-2030)
  • Figure 45: Lateral Flow Readers/Assay Market in RoW by Technique (2021-2030)
  • Figure 46: Lateral Flow Readers/Assay Market in RoW by Application (2021-2030)
  • Figure 47: Lateral Flow Readers/Assay Market in RoW by End User (2021-2030)
  • Figure 48: Lateral Flow Readers/Assay Market in RoW by Region (2021-2030)
  • Figure 49: Lateral Flow Readers/Assay Market in Middle East (2021-2030)
  • Figure 50: Lateral Flow Readers/Assay Market in Africa (2021-2030)
  • Figure 51: Lateral Flow Readers/Assay Market in South America (2021-2030)
  • Figure 52: Market Drivers
  • Figure 53: Market Barriers
  • Figure 54: Marker Opportunities
  • Figure 55: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0530

Lateral Flow Readers/Assay Market By Product (Readers [Bench-Top Readers, Digital/Mobile Readers], Kits & Reagents), By Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), By Application (Clinical Testing [Pregnancy Testing, Infectious Diseases Testing, Cardiac Marker Testing, Others], Drug Development & Quality Testing, Others), By End-User (Hospitals & Clinics, Home Care, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to rising incidence of infectious diseases and rapid technological advancements in the immunodiagnostic product arena

Global Lateral Flow Readers/Assay Market was valued at USD 8.64 billion in 2023, growing at a CAGR of 5.41% during the forecast period from 2024 to 2030 to reach USD 12.15 billion by 2030. The Lateral Flow Readers/Assay market is witnessing positive growth owing to the growing incidence of infectious diseases such as the sudden outbreak of COVID-19, and the increasing cases of pregnancy testing across the globe. Moreover, rapid technological advancements in the immunodiagnostic product arena, the rapidly aging population, increasing demand for point-of-care testing along rising consumer awareness regarding quick diagnostics, among others are some of the key factors responsible for the Lateral Flow Readers/Assay market growth, thereby contributing to the Global Lateral Flow Readers/Assay market during the forecast period from 2024-2030.

Lateral Flow Readers/Assay Market Dynamics:

The Lateral Flow Readers/Assay market is witnessing a growth in product demand owing to various reasons, one of the major reasons being the rising cases of infectious diseases across the globe. According to the 2022 data published by the UNAIDS, the Joint United Nations Programme on HIV/AIDS, an innovative joint venture of the United Nations family, approximately 37.7 million population globally were living with HIV and around 1.5 million new HIV cases were reported in the year 2020. Additionally, product approval for the detection and differentiation of HIV infection for personalized management of patients with HIV bolsters the Lateral Flow Readers/Assay market growth.

Another factor responsible for the growth of the Lateral Flow Readers/Assay market is the onset of the COVID-19 pandemic and the urgency felt for the need of the diagnostic tests in order to contain the spread of the COVID-19 infection. The high virulence associated with the SARS- COV-2 virus led to the panic situation across the globe and led to various stages of lockdowns globally. This led to the exigent need for diagnostic methods and kits for the detection of the SARS-COV-2 virus with the aim to design better care for both infected and uninfected population groups.

Moreover, technological advancements led to the development of numerous rapid antigen tests in order to serve the need for reliable novel diagnostic kits to meet the urgency created by the pandemic thereby positively impacting the Lateral Flow Readers/Assay market growth during the forecast period (2024-2030). For instance, in June 2022, Novacyt introduced two COVID-19 antigen lateral flow tests, expanding its COVID-19 product portfolio, mainly in the point-of-care segment.

Therefore, in order to facilitate the diagnosis of different infectious diseases, Lateral Flow Readers/Assay are witnessing an increase in demand, leading to overall Lateral Flow Readers/Assay market growth.

Hence, early detection is essential for a cure because survival is dependent on the treatment pathway for the disease. With proper testing, treatment becomes better. Therefore, the increasing prevalence of infectious diseases is projected to result in the growing demand for Lateral Flow Readers/Assay, thereby contributing to the growth of the Lateral Flow Readers/Assay market during the forecast period from 2024-2030.

However, challenges in the development of accurate diagnostic tests and equipment and variations in test findings may be certain limiting factors of the Lateral Flow Readers/Assay market growth.

Lateral Flow Readers/Assay Market Segment Analysis:

Lateral Flow Readers/Assay Market By Product (Readers [Bench-top Readers, Digital/Mobile Readers], Kits & Reagents), By Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), By Application (Clinical Testing [Pregnancy Testing, Infectious Diseases Testing, Cardiac Marker Testing, Others], Drug Development & Quality Testing, Others), By End-User (Hospitals & Clinics, Home Care, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the Product segment of the Lateral Flow Readers/Assay market, the Kits & Reagents subsegments are estimated to hold a higher share in the Lateral Flow Readers/Assay market during the forecast period (2024-2030). This can be attributed to the specific features associated with these products.

The dominance of this segment is due to the portability of these products. The Kits & Reagents are a reliable and familiar format that enables frequent mass testing among end-users. With no equipment required, these products are an important tool to manage risk by quickly identifying infectious people so they don't spread the disease to others. Moreover, several market players have a strong portfolio of Kits & Reagents and are now launching new products in this segment.

Furthermore, the increase in Emergency use Authorizations (EUA) test by the US FDA for the detection of COVID-19 will also contribute to the segmental growth. For instance, on August 26, 2020, Abbott received the US Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for its BinaxNOW(TM) COVID-19 Ag Card rapid test for detection of COVID-19 infection. It is highly portable, affordable, and provides results in 15 minutes.

Therefore, considering the advantages associated with Kits & Reagents, this product category is expected to generate significant revenue share eventually contributing to the overall growth of the global Lateral Flow Readers/Assay market in the forecast period.

North America is expected to dominate the overall Lateral Flow Readers/Assay Market:

Among all the regions, North America is expected to account for the largest share in the Global Lateral Flow Readers/Assay market. Factors such as the growing burden of infectious disease in the region, presence of key market players, rising demand for technologically advanced point-of-care diagnostics platforms, increasing awareness for early detection among others are expected to aid in the growth of North America Lateral Flow Readers/Assay Market.

For instance, as per the data revealed by the Centres for Disease Control and Prevention (CDC) 2022, there were 37,377 people diagnosed with HIV in the US in the year 2018. Moreover, the data also revealed the new salmonella cases and Lyme disease cases in the region were 60,999 and 33,666 respectively in 2018.

Thus, the rising infectious disease burden in the regions will escalate the demand for the Lateral Flow Readers/Assay market.

In addition, the presence of global as well as regional manufacturers such as Qiagen, Roche, Abbott, among others active in developing the Lateral Flow Readers/Assay product will also boost the market. Also, improving healthcare infrastructure, and government initiatives in raising awareness regarding Lateral Flow Readers/Assay will contribute to the Lateral Flow Readers/Assay market growth in these regions.

Additionally, the presence of key manufacturers in the region and their strategic business activities will also contribute to the Lateral Flow Readers/Assay market growth. For instance, on August 25, 2022, Becton, Dickinson, and Company received the US FDA Emergency Use Authorization (EUA) for the BD Veritor(TM) At-Home COVID-19 Test - the first at-home COVID-19 rapid antigen test to use computer vision technology in a smartphone to interpret and provide a digital display of testing results. The test does not require a prescription, a laboratory, or a long wait for results. These kinds of product launches in the local markets drive the product demand in the market.

Furthermore, the increased emphasis on product development activities and the high interest of device manufacturers in accessing local markets further aid in the growth of the regional markets for Lateral Flow Readers/Assay.

Therefore, the interplay of various factors such as the presence of a large patient population, encouraging reimbursement policies as well as new product launches in the region is expected to boost the North America Lateral Flow Readers/Assay market during the forecast period.

Lateral Flow Readers/Assay Market Key Players:

Some of the key market players operating in the Lateral Flow Readers/Assay market include Abbott, Quidel Corporation, Danaher, Siemens Healthineers, F. Hoffman-La Roche AG, LumiraDx, Becton, Dickinson and Company, Eurofins Technologies, bioMerieux SA, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Hologic, Inc., PerkinElmer Inc., QIAGEN, Merck KGaA, OPERON, Abingdon Health, DIALUNOX, 3B BlackBio Biotech India Ltd., ADS Biotec Inc. (ADSTEC) and others.

Recent Developmental Activities in the Lateral Flow Readers/Assay Market:

On January 21, 2022, LumiraDx announced multinational approvals of its SARS-CoV-2 Antigen Test. With approvals in Japan and Brazil, the fast, accurate LumiraDx SARS-CoV-2 Antigen Test was made available to patients in more than 30 nations worldwide.

On January 11, 2022, ADS Biotec announced the European launch and immediate availability of its COVID-19 Rapid Antigen Test. The company obtained a CE mark for the industry's first Rapid Antigen Test that works with both nasal swab and blood serum, using proven fluorescence immunochromatographic lateral flow technology, providing an easy-to-use test for COVID-19 infection within 15 minutes.

On October 14, 2020, Siemens Healthineers has launched its Clinitest Rapid COVID-19 Antigen Test in Europe, which can identify persons infected with SARS-CoV-2 in 15 minutes.

Key Takeaways from the Lateral Flow Readers/Assay Market Report Study

  • Market size analysis for current Lateral Flow Readers/Assay market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Lateral Flow Readers/Assay market.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
  • Key companies dominating the global Lateral Flow Readers/Assay market.
  • Various opportunities available for the other competitor in the Lateral Flow Readers/Assay market space.
  • What are the top performing segments in 2023? How these segments will perform in 2030.
  • Which is the top-performing regions and countries in the current Lateral Flow Readers/Assay market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Lateral Flow Readers/Assay market growth in the coming future?

Target Audience who can be benefited from this Lateral Flow Readers/Assay Market Report Study

  • Lateral Flow Readers/Assay products providers
  • Research organizations and consulting companies
  • Lateral Flow Readers/Assay-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Lateral Flow Readers/Assay
  • Various End-users who want to know more about the Lateral Flow Readers/Assay market and latest technological developments in the Lateral Flow Readers/Assay market.

Frequently Asked Questions for Lateral Flow Readers/Assay Market:

1. What are Lateral Flow Readers/Assay?

Lateral Flow Readers/Assay is a simple to use diagnostic device used to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, foodstuffs, or animal feeds. The most commonly known type of lateral flow rapid test strip is the pregnancy test.

2. What is the market for Global Lateral Flow Readers/Assay?

Global Lateral Flow Readers/Assay Market was valued at USD 8.64 billion in 2023, growing at a CAGR of 5.41% during the forecast period from 2024 to 2030 to reach USD 12.15 billion by 2030.

3. What are the drivers for the Global Lateral Flow Readers/Assay Market?

The Lateral Flow Readers/Assay market is witnessing a positive market growth owing to the growing incidence of infectious diseases such as the sudden outbreak of COVID-19, and the increasing cases of pregnancy testing across the globe. Moreover, rapid technological advancements in the immunodiagnostic product arena, the rapidly aging population, increasing demand for point-of-care testing along with rising consumer awareness regarding quick diagnostics, among others.

4. Who are the key players operating in the Global Lateral Flow Readers/Assay Market?

Some of the key market players operating in the Lateral Flow Readers/Assay market include Abbott, Quidel Corporation, Danaher, Siemens Healthineers, F. Hoffman-La Roche AG, LumiraDx, Becton, Dickinson and Company, Eurofins Technologies, bioMerieux SA, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Hologic, Inc., PerkinElmer Inc., QIAGEN, Merck KGaA, OPERON, Abingdon Health, DIALUNOX, 3B BlackBio Biotech India Ltd., ADS Biotec Inc. (ADSTEC) and others.

5. Which region has the highest share in the Lateral Flow Readers/Assay Market?

North America is expected to hold the highest share in the revenue in the Lateral Flow Readers/Assay market during the forecast period. Factors such as the growing burden of infectious disease in the region, presence of key market players, rising demand for technologically advanced point-of-care diagnostics platforms, increasing awareness for early detection among others are expected to aid in the growth of North America Lateral Flow Readers/Assay Market.

Table of Contents

1.Lateral Flow Readers/Assay Market Report Introduction

2.Lateral Flow Readers/Assay Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Lateral Flow Readers/Assay Market Key Factors Analysis

  • 4.1. Lateral Flow Readers/Assay Market Drivers
    • 4.1.1. The Growing Incidence of Infectious Diseases
    • 4.1.2. Increasing Cases of Pregnancy Testing
    • 4.1.3. Rapid Technological Advancements in the Immunodiagnostic Product Arena
  • 4.2. Lateral Flow Readers/Assay Market Restraints and Challenges
    • 4.2.1. Challenges in the Development of Accurate Diagnostic Tests and Equipment
    • 4.2.2. Variations in Test Findings
  • 4.3. Lateral Flow Readers/Assay Market Opportunities
    • 4.3.1. Rising Strategic Business Activities among the Manufacturers
    • 4.3.2. Targeting Emerging Markets for Product Launches

5. Lateral Flow Readers/Assay Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Lateral Flow Readers/Assay Market

7. Lateral Flow Readers/Assay Market Layout

  • 7.1. By Product
    • 7.1.1. Readers
      • 7.1.1.1. Bench-top Readers
      • 7.1.1.2. Digital/Mobile Readers
    • 7.1.2. Kits & Reagents
  • 7.2. By Technique
    • 7.2.1. Sandwich Assays
    • 7.2.2. Competitive Assays
    • 7.2.3. Multiplex Detection Assays
  • 7.3. By Application
    • 7.3.1. Clinical Testing
      • 7.3.1.1. Pregnancy Testing
      • 7.3.1.2. Infectious Diseases Testing
      • 7.3.1.3. Cardiac Marker Testing
      • 7.3.1.4. Others
    • 7.3.2. Drug Development & Quality Testing
    • 7.3.3. Others
  • 7.4. By End User
    • 7.4.1. Hospitals & Clinics
    • 7.4.2. Home Care
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. North America Lateral Flow Readers/Assay Market, by Product
      • 7.5.1.2. North America Lateral Flow Readers/Assay Market, by Technique
      • 7.5.1.3. North America Lateral Flow Readers/Assay Market, by Application
      • 7.5.1.4. North America Lateral Flow Readers/Assay Market, by End User
      • 7.5.1.5. North America Lateral Flow Readers/Assay Market, by Country
      • 7.5.1.5.1. United States
      • 7.5.1.5.2. Canada
      • 7.5.1.5.3. Mexico
    • 7.5.2. Europe
      • 7.5.2.1. Europe Lateral Flow Readers/Assay Market, by Product
      • 7.5.2.2. Europe Lateral Flow Readers/Assay Market, by Technique
      • 7.5.2.3. Europe Lateral Flow Readers/Assay Market, by Application
      • 7.5.2.4. Europe Lateral Flow Readers/Assay Market, by End User
      • 7.5.2.5. Europe Lateral Flow Readers/Assay Market, by Country
      • 7.5.2.5.1. France
      • 7.5.2.5.2. Germany
      • 7.5.2.5.3. United Kingdom
      • 7.5.2.5.4. Italy
      • 7.5.2.5.5. Spain
      • 7.5.2.5.6. Russia
      • 7.5.2.5.7. Rest of Europe
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. Asia-Pacific Lateral Flow Readers/Assay Market, by Product
      • 7.5.3.2. Asia-Pacific Lateral Flow Readers/Assay Market, by Technique
      • 7.5.3.3. Asia-Pacific Lateral Flow Readers/Assay Market, by Application
      • 7.5.3.4. Asia-Pacific Lateral Flow Readers/Assay Market, by End User
      • 7.5.3.5. Asia-Pacific Lateral Flow Readers/Assay Market, by Country
      • 7.5.3.5.1. China
      • 7.5.3.5.2. Japan
      • 7.5.3.5.3. India
      • 7.5.3.5.4. Australia
      • 7.5.3.5.5. South Korea
      • 7.5.3.5.6. Rest of Asia Pacific
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. RoW Lateral Flow Readers/Assay Market, by Product
      • 7.5.4.2. RoW Lateral Flow Readers/Assay Market, by Technique
      • 7.5.4.3. RoW Lateral Flow Readers/Assay Market, by Application
      • 7.5.4.4. RoW Lateral Flow Readers/Assay Market, by End User
      • 7.5.4.5. RoW Lateral Flow Readers/Assay Market, by Country
      • 7.5.4.5.1. Middle East
      • 7.5.4.5.2. Africa
      • 7.5.4.5.3. South America

8. Lateral Flow Readers/Assay Market Global Company Share Analysis - Key 3-5 Companies

9. Lateral Flow Readers/Assay Market Company and Product Profiles

  • 9.1. Abbott
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Quidel Corporation
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Danaher
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Siemens Healthineers
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. F. Hoffman-La Roche AG
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. LumiraDx
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Becton, Dickinson, and Company
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Eurofins Technologies
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. bioMerieux SA
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Bio-Rad Laboratories, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Thermo Fisher Scientific
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Hologic, Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. PerkinElmer Inc.
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. QIAGEN
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Merck KGaA
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. OPERON
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. Abingdon Health
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. DIALUNOX
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. 3B BlackBio Biotech India Ltd.
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20. ADS Biotec Inc. (ADSTEC)
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. PROJECT APPROACH

12. About DelveInsight

13. Disclaimer & Contact Us